Shopping Cart (0)
My Account

 Shopping Cart
Conferences | Training Courses | Market Reports | Managed Events | Past Conferences | Update Me
SELECTBIO Conferences 3D-Culture, Organoids and Organs-on-Chips 2021
Conferences  \  3D-Culture, Organoids and Organs-on-Chips 2021  \  Agenda  \  Anthony Davies
RegisterLogin

Anthony Davies's Biography


Anthony Davies, Adjunct Assistant Professor, Trinity College Dublin

Prof. Davies’ scientific research has focused on the development of advanced in vitro cell-based models and the rapidly growing field of high content screening and analysis. He has overseen and led the establishment of Research Centers in Europe and Australia where his work was centered on understanding human disease. In 2005 he set up the Irish National Centre for High Content Screening and Analysis (INCHSA), based in the Department of Clinical Medicine at Trinity College Dublin, one of the first purpose built academic screening centers of its kind in Europe. More recently he set up Translational Cell imaging Queensland (TCIQ) in collaboration with GE Healthcare. This centre is in the Translational Research Institute, on the Princess Alexandra Hospital campus in Brisbane, Australia. Anthony has developed and commercialized a number of new technologies, most notably Happy Cell ASM, a liquid 3D cellular scaffold specifically designed for use in automated drug discovery.

Anthony Davies Image

Rapidly Deployable and Robust 3D Cell-based Assay Systems Developed to Accelerate Biomedical Research

Tuesday, 23 March 2021 at 12:30

Add to Calendar ▼2021-03-23 12:30:002021-03-23 13:30:00Europe/LondonRapidly Deployable and Robust 3D Cell-based Assay Systems Developed to Accelerate Biomedical Research3D-Culture, Organoids and Organs-on-Chips 2021 in SELECTBIOenquiries@selectbiosciences.com

Historically, biomedical researchers have utilized two-dimensional (2D) cell culture models to study disease and evaluate new therapeutic approaches. However, over time there has been a shift from these traditional approaches towards three-dimensional (3D) cell culture methods. This transition has brought with it an influx of technologies capable supporting the formation and growth these new 3D cellular models. Over time strong evidence is emerging that many of these 3D cell culture approaches offer a more biologically relevant output than those derived from 2D cell culture. As the use of these 3D approaches increases, so does the demand for increased throughput and scalability. Over time it has become evident that many of these technologies do not perform well in automated lab environments hence rate limiting progress. In this presentation we cover our work in the area of 3D cell culture using world’s first liquid scaffold and the very latest solid state microplate bioreactor systems have enhanced our capability to automate and scale 3D cell based assays.

Add to Calendar ▼2021-03-22 00:00:002021-03-23 00:00:00Europe/London3D-Culture, Organoids and Organs-on-Chips 20213D-Culture, Organoids and Organs-on-Chips 2021 in SELECTBIOenquiries@selectbiosciences.com


Corporate Sponsors